104 related articles for article (PubMed ID: 8099730)
1. 2-Chlorodeoxyadenosine in haematological malignancies.
Castaigne S
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):13-4. PubMed ID: 8099730
[TBL] [Abstract][Full Text] [Related]
2. 2-Chlorodeoxyadenosine: hairy cell leukemia takes a surprising turn.
Beutler E; Carson DA
Blood Cells; 1993; 19(3):559-68; discussion 569-72. PubMed ID: 8018939
[TBL] [Abstract][Full Text] [Related]
3. 2-Chloro-2'-deoxyadenosine (2CdA) biochemical aspects of antileukemic efficacy.
Fabianowska-Majewska K; Wyczechowska D
Acta Pol Pharm; 1996; 53(4):231-9. PubMed ID: 9415193
[TBL] [Abstract][Full Text] [Related]
4. Cladribine for the treatment of hematologic malignancies.
Baltz JK; Montello MJ
Clin Pharm; 1993 Nov; 12(11):805-13; quiz 860-2. PubMed ID: 7903917
[TBL] [Abstract][Full Text] [Related]
5. Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignancies.
Bryson HM; Sorkin EM
Drugs; 1993 Nov; 46(5):872-94. PubMed ID: 7507037
[TBL] [Abstract][Full Text] [Related]
6. 2-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive Nucleoside.
Beutler E; Piro LD; Saven A; Kay AC; McMillan R; Longmire R; Carrera CJ; Morin P; Carson DA
Leuk Lymphoma; 1991; 5(1):1-8. PubMed ID: 27463204
[TBL] [Abstract][Full Text] [Related]
7. [Clinical pharmacology of 2-chlorodeoxyadenosine (Cladribine)].
Góra-Tybor J; Robak T
Przegl Lek; 1996; 53(8):614-8. PubMed ID: 8999463
[TBL] [Abstract][Full Text] [Related]
8. 2-Chlorodeoxyadenosine: a new nucleoside agent effective in the treatment of lymphoid malignancies.
Saven A; Piro LD
Leuk Lymphoma; 1993; 10 Suppl():43-9. PubMed ID: 8097654
[No Abstract] [Full Text] [Related]
9. 2-Chlorodeoxyadenosine: a newer purine analog active in the treatment of indolent lymphoid malignancies.
Saven A; Piro LD
Ann Intern Med; 1994 May; 120(9):784-91. PubMed ID: 7908507
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of 34 cases of hairy cell leukemia treated with interferon-alpha and/or 2-chlorodeoxyadenosine.
Zaja F; Fanin R; Silvestri F; Russo D; Infanti L; Baccarani M
Haematologica; 1997; 82(4):468-70. PubMed ID: 9299866
[TBL] [Abstract][Full Text] [Related]
11. 2-Chlorodeoxyadenosine: treatment of hairy cell leukemia, chronic lymphocytic leukemia, and lymphocytic lymphoma.
Piro LD
Semin Hematol; 1993 Oct; 30(4 Suppl 6):28-30. PubMed ID: 7908756
[No Abstract] [Full Text] [Related]
12. Cladribine: from the bench to the bedside--focus on hairy cell leukemia.
Greyz N; Saven A
Expert Rev Anticancer Ther; 2004 Oct; 4(5):745-57. PubMed ID: 15485311
[TBL] [Abstract][Full Text] [Related]
13. Cladribine. Ortho Biotech Inc.
Tortorella C; Rovaris M; Filippi M
Curr Opin Investig Drugs; 2001 Dec; 2(12):1751-6. PubMed ID: 11892941
[TBL] [Abstract][Full Text] [Related]
14. New chemotherapeutic agent: 2-chlorodeoxyadenosine.
Beutler E
Semin Hematol; 1994 Jan; 31(1):40-5. PubMed ID: 7907189
[No Abstract] [Full Text] [Related]
15. [Cladribine].
Ogura M
Gan To Kagaku Ryoho; 2003 Feb; 30(2):309-17. PubMed ID: 12610885
[TBL] [Abstract][Full Text] [Related]
16. Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia.
Rai KR
Semin Oncol; 1998 Jun; 25(3 Suppl 7):19-22. PubMed ID: 9671325
[TBL] [Abstract][Full Text] [Related]
17. [2-chlorodeoxyadenosine (2-CDA)--a new antineoplastic and immunosuppressive drug].
Robak T; Grieb P
Acta Haematol Pol; 1992; 23(3):141-8. PubMed ID: 1362851
[No Abstract] [Full Text] [Related]
18. [New analogs of deoxyadenosine for treatment of lymphoid malignancies].
Robak T
Przegl Lek; 1992; 49(10):355-8. PubMed ID: 1364050
[No Abstract] [Full Text] [Related]
19. Comparative efficacy of the newer nucleosides (fludarabine, 2'-deoxycoformycin, and 2-chlorodeoxyadenosine) in the treatment of indolent lymphoid malignancies.
Saven A
Semin Hematol; 1993 Oct; 30(4 Suppl 6):31-3. PubMed ID: 7908757
[No Abstract] [Full Text] [Related]
20. The role of cladribine in the treatment of lymphoid malignancies.
Nelson MC; Hogan DK
Oncol Nurs Forum; 1995 Oct; 22(9):1395-400. PubMed ID: 8539180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
